Sep 30, 2013

Gilead Sciences Q3 2013 Earnings Report

Total Revenue
$2.78B
Previous year: $2.43B
+14.4%
EPS
$0.52
Previous year: $0.5
+4.0%
Gross Profit
$2.1B
Previous year: $1.83B
+14.8%
Cash and Equivalents
$2.01B
Previous year: $1.55B
+29.7%
Total Assets
$22.5B
Previous year: $21B
+7.2%

Gilead Sciences

Gilead Sciences